The anti-tnf certolizumab pegol in combination with methotrexate is significantly more effective than methotrexate alone in the treatment of patients with active rheumatoid arthritis: Preliminary results from the rapid 1 study

被引：0
|
作者：
Keystone, E. [1 ]
Mason, D. [2 ]
Combe, B.
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] R&D UCB Inc, Atlanta, GA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
    Bi, L.
    Li, Y.
    He, L.
    Xu, H.
    Jiang, Z.
    Wang, Y.
    Li, X.
    Wei, W.
    Gu, J.
    Wang, G.
    Zhang, Z.
    Zhou, B.
    Liu, Y.
    Wu, Z.
    Liu, H.
    He, D.
    Lv, Z.
    Li, Z.
    Zuo, X.
    Dong, L.
    Wu, H.
    Zhang, H.
    Chen, H.
    Bao, C.
    Zhang, Z.
    Zhang, M.
    Song, H.
    Zheng, Y.
    Jiang, L.
    Liu, X.
    Boehnlein, M.
    Dunkel, J.
    Shao, J.
    Harris, K.
    Li, Z.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 227 - 234
  • [32] Certolizumab pegol added onto methotrexate improves physical functioning and reduces pain in patients with rheumatoid arthritis who have an incomplete response to methotrexate: Data from rapid 2
    Schiff, M.
    Keininger, D. L.
    Tahiri-Fitzgerald, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 187 - 187
  • [33] The safety of Abatacept in patients with active rheumatoid arthritis and insufficient response to an anti-TNF treatment: Results of the ARRIVE study
    Rieger, H. J.
    Schiff, M.
    Pritchard, C.
    Teng, J.
    Bahrt, K.
    Genovese, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 26 - 27
  • [34] Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNFα therapies
    Keystone, E. C.
    Burmester, G. R.
    Furie, R. A.
    Loveless, J. E.
    Emery, P.
    Isaacs, J.
    Jubb, R.
    Dawes, P.
    Cravets, M. W.
    Magrini, F.
    [J]. RHEUMATOLOGY, 2006, 45 : I46 - I47
  • [35] Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients nave to both drugs
    Schipper, Lydia G.
    Fransen, Jaap
    Barrera, Pilar
    Van Riel, Piet L. C. M.
    [J]. RHEUMATOLOGY, 2009, 48 (07) : 828 - 833
  • [36] Effects of Methotrexate on Anti-TNF Treatment in Rheumatoid Arthritis: An in-Depth Analysis of a Prospective Observational Study with Adalimumab.
    Schmalzing, Marc
    Behrens, Frank
    Scharbatke, Eva C.
    Koehm, Michaela
    Wittig, Bianca
    Greger, Gerd
    Burkhardt, Harald
    Tony, Hans-Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1274 - S1274
  • [37] Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study
    Tanaka, Yoshiya
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Miyasaka, Nobuyuki
    Koike, Takao
    Kanazawa, Minoru
    Oba, Takuya
    Yoshinari, Toru
    Baker, Daniel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 817 - 824
  • [38] Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF alpha blocker failure
    Kekow, Joern
    Mueller-Ladner, Ulf
    Schulze-Koops, Hendrik
    [J]. BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 191 - 199
  • [39] Treatment with abatacept (CTLA4lg; BMS-1 88667) in combination ion with methotrexate significantly improves physical function over 1 year in patients with active rheumatoid arthritis compared with methotrexate alone
    Emery, P
    Tugwell, P
    Bombardier, C
    Nuamah, I
    Aranda, R
    Becker, J
    Li, T
    Maclean, R
    Williams, GR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 518 - 518
  • [40] Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
    Capell, Hilary A.
    Madhok, Rajan
    Porter, Duncan R.
    Munro, Robin A. L.
    McInnes, Iain B.
    Hunter, John A.
    Steven, Malcolm
    Zoma, Asad
    Morrison, Elaine
    Sambrook, Martin
    Poon, Fat Wui
    Hampson, Rosemary
    McDonald, Fiona
    Tierney, Ann
    Henderson, Neil
    Ford, Ian
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) : 235 - 241
12345